Implantable Cardioverter Defibrillator (ICD) Market Size, Trends and Growth Analysis By Product (Regular ICD, CRT-D, Subcutaneous-ICD, Others), By Indication (Myocardial ischemia, Acute myocardial infarction, Electrolyte imbalance and drug toxicity) and By End User (Hospitals and clinics, Ambulatory surgical centers) – Forecast to 2032

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D and Designing

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-Sales Review

Chapter 6. Global Implantable Cardioverter Defibrillator (ICD) Market, by Product Type

6.1 Overview

6.2 Regular ICD

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Cardiac Resynchronization Therapy Defibrillators (CRT-D)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Subcutaneous-ICD (S-ICD)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Implantable Cardioverter Defibrillator (ICD) Market, by Indication

7.1 Overview

7.2 Acute Myocardial Infarction

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Myocardial Ischemia

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Electrolyte Imbalance and Drug Toxicity

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Implantable Cardioverter Defibrillator (ICD) Market, by End User

8.1 Overview

8.2 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Implantable Cardioverter Defibrillator (ICD) Market, by Region

9.1 Overview

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Overview

10.2 Competitive Analysis

Chapter 11. Company Profile

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Products/Services Offered

11.1.3 Financial Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.1.6 Key Strategies

11.2 BIOTRONIK

11.2.1 Company Overview

11.2.2 Products/Services Offered

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategies

11.3 Boston Scientific Corporation

11.3.1 Company Overview

11.3.2 Products/Services Offered

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.3.6 Key Strategies

11.4 Medtronic

11.4.1 Company Overview

11.4.2 Products/Services Offered

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.4.6 Key Strategies

11.5 MicroPort Scientific Corporation

11.5.1 Company Overview

11.5.2 Products/Services Offered

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategies

11.6 Koninklijke Philips N.V.

11.6.1 Overview

11.6.2 Products/Services Offered

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.6.6 Key Strategies

11.7 Nihon Kohden Corporation

11.7.1 Overview

11.7.2 Products/Services Offered

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7.6 Key Strategies

11.8 Progetti Srl

11.8.1 Overview

11.8.2 Products/Services Offered

11.8.3 Financial Overview

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8.6 Key Strategies

9.9 Fukuda Denshi Co., Ltd

9.9.1 Overview

9.9.2 Products/Services Offered

9.9.3 Financial Overview

9.9.4 Key Developments

9.9.5 SWOT Analysis

9.9.6 Key Strategies

11.10 Getinge AB

11.10.1 Overview

11.10.2 Products/Services Offered

11.10.3 Financial Overview

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10.6 Key Strategies

11.11 ZOLL Medical Corporation

11.11.1 Overview

11.11.2 Products/Services Offered

11.11.3 Financial Overview

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.11.6 Key Strategies

11.12 Others

Chapter 12 Appendix

12.1 References

12.2 Related Reports

LIST OF TABLES

Table 1 Global Implantable Cardioverter Defibrillator (ICD) Market Synopsis, 2020-2027

Table 2 Global Implantable Cardioverter Defibrillator (ICD) Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 4 Global Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 5 Global Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 6 Global Implantable Cardioverter Defibrillator (ICD) Market, by Region, 2020-2027 (USD Million)

Table 7 Americas: Implantable Cardioverter Defibrillator (ICD) Market, by Region, 2016 and 2025

Table 6 Americas: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 9 Americas: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 10 Americas: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 11 North America: Implantable Cardioverter Defibrillator (ICD) Market, by Country, 2020-2027 (USD Million)

Table 12 North America: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 13 North America: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 14 North America: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 15 Latin America: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 16 Latin America: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 17 Latin America: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 18 Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Region, 2020-2027 (USD Million)

Table 19 Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 20 Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 21 Europe: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 22 Western Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Country, 2020-2027 (USD Million)

Table 23 Western Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 24 Western Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 25 Western Europe: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 26 Eastern Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 27 Eastern Europe: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 28 Eastern Europe: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Implantable Cardioverter Defibrillator (ICD) Market, by Country, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 31 Asia-Pacific: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 32 Asia-Pacific: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)

Table 33 Middle East & Africa: Implantable Cardioverter Defibrillator (ICD) Market, by Region, 2020-2027 (USD Million)

Table 34 Middle East & Africa: Implantable Cardioverter Defibrillator (ICD) Market, by Product Type, 2020-2027 (USD Million)

Table 35 Middle East & Africa: Implantable Cardioverter Defibrillator (ICD) Market, by Indication, 2020-2027 (USD Million)

Table 36 Middle East & Africa: Implantable Cardioverter Defibrillator (ICD) Market, by End User, 2020-2027 (USD Million)  

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Implantable Cardioverter Defibrillator (ICD) Market

Figure 3 Market Dynamics for Global Implantable Cardioverter Defibrillator (ICD) Market

Figure 4 Global Implantable Cardioverter Defibrillator (ICD) Market Share, by Product Type, 2020 (%)

Figure 5 Global Implantable Cardioverter Defibrillator (ICD) Market Size, by Product Type, 2016 (USD Million)

Figure 6 Global Implantable Cardioverter Defibrillator (ICD) Market Share, by Indication, 2020 (%)

Figure 7 Global Implantable Cardioverter Defibrillator (ICD) Market Size, by Indication, 2016 (USD Million)

Figure 6 Global Implantable Cardioverter Defibrillator (ICD) Market Share, by End User, 2020 (%)

Figure 9 Global Implantable Cardioverter Defibrillator (ICD) Market Size, by End User, 2016 (USD Million)

Figure 10 Global Implantable Cardioverter Defibrillator (ICD) Market Share, by Region, 2020 (%)

Figure 11 Americas: Implantable Cardioverter Defibrillator (ICD) Market Share, by Region, 201(%)

Figure 12 North America: Implantable Cardioverter Defibrillator (ICD) Market Share, by Country, 2020 (%)

Figure 13 Europe: Implantable Cardioverter Defibrillator (ICD) Market Share, by Region, 2020 (%)

Figure 14 Western Europe: Implantable Cardioverter Defibrillator (ICD) Market Share, by Country, 2020 (%)

Figure 15 Asia-Pacific: Implantable Cardioverter Defibrillator (ICD) Market Share, by Country, 2020 (%)

Figure 16 Middle East & Africa: Implantable Cardioverter Defibrillator (ICD) Market Share, by Region, 2020 (%)

Figure 17 Global Implantable Cardioverter Defibrillator (ICD) Market: Company Share Analysis, 2020 (%)

Figure 18 Abbott: Key Financials

Figure 19 Abbott: Segmental Revenue

Figure 20 Abbott: Geographical Revenue

Figure 21 BIOTRONIK: Key Financials

Figure 22 BIOTRONIK: Segmental Revenue

Figure 23 BIOTRONIK: Geographical Revenue

Figure 24 Boston Scientific Corporation: Key Financials

Figure 25 Boston Scientific Corporation: Segmental Revenue

Figure 26 Boston Scientific Corporation: Geographical Revenue

Figure 27 Medtronic: Key Financials

Figure 28 Medtronic: Segmental Revenue

Figure 29 Medtronic: Geographical Revenue

Figure 30 MicroPort Scientific Corporation: Key Financials

Figure 31 MicroPort Scientific Corporation: Segmental Revenue

Figure 32 MicroPort Scientific Corporation: Geographical Revenue

Figure 33 Koninklijke Philips N.V.: Key Financials

Figure 34 Koninklijke Philips N.V.: Segmental Revenue

Figure 35 Koninklijke Philips N.V.: Geographical Revenue

Figure 36 Nihon Kohden Corporation: Key Financials

Figure 37 Nihon Kohden Corporation: Segmental Revenue

Figure 38 Nihon Kohden Corporation: Geographical Revenue

Figure 39 Progetti Srl: Key Financials

Figure 40 Progetti Srl: Segmental Revenue

Figure 41 Progetti Srl: Geographical Revenue

Figure 42 Fukuda Denshi Co., Ltd: Key Financials

Figure 43 Fukuda Denshi Co., Ltd: Segmental Revenue

Figure 44 Fukuda Denshi Co., Ltd: Geographical Revenue

Figure 45 Getinge: Key Financials

Figure 46 Getinge: Segmental Revenue

Figure 47 Getinge: Geographical Revenue

Figure 48 ZOLL Medical Corporation: Key Financials

Figure 49 ZOLL Medical Corporation: Segmental Revenue

Figure 50 ZOLL Medical Corporation: Geographical Revenue